Top news of the week: 18.01.2022.
Healthcare
ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme
Investigator-initiated multicenter Phase I study in glioblastoma with CA XII-targeting, 177Lu radiolabeled antibody Fab fragment (LuCaFab) in preparation, led by University of …
Welcome to Bharatt's Climb to Fight Cancer
I am thrilled to be joining the Fred Hutch’s Climb to Fight Cancer initiative -- a trek to the Mt. Having worked in biotech for almost three decades, I am a big believer in the …
CEO Message
The company has made meaningful progress towards our goal of transforming the way cancer is treated through our highly innovative approach of targeting the tumor microenvironment …
The Everest Base Camp Climb to Fight Cancer
The Everest Base Camp Climb to Fight Cancer Science is at a moment of tremendous possibility. Support Fred Hutch by sponsoring a team of biotech leaders on a trek to Everest Base …
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer’s, diabetes and asthma Report also examines key therapeutic ...
Biotech Co. Partners With Life Sciences Firms Research Report
2seventy entered agreements with Novo Nordisk and Genevant to get an in vivo gene editing treatment for hemophilia A developed, noted a Wedbush report.
Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation
About this Course 49th Annual Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation Tufts CSDD’s Postgraduate Course in Clinical Pharmacology, Drug …
Open Call for Regulatory Experts
One task of the EATRIS-Plus project is to expand catalog of services by setting up an EATRIS Regulatory Task Force composed by a maximum of ten EATRIS Regulatory Experts. Foreseen …